Capricor Therapeutics | CAPR - Ordinary Share Capital


Capricor Therapeutics reported $57.37M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Bioline Rx USD 2.62B 10.16M Jun/2026
Capricor Therapeutics USD 57.37M 11.65M Dec/2025
Cipla INR 807.87M 88K Sep/2026
Cytokinetics USD 138.76M 14.33M Jun/2026
Geron USD 640.9M 2.54M Mar/2026
Grifols EUR 680.58M 846.11K Dec/2025
Immunic USD 120.38M 21.73M Dec/2025
J&J USD 2.41B 1.64M Jun/2026
Plus Therapeutics USD 275K 138.4M Mar/2026
Prothena USD 51.74M 1.33M Jun/2026
PTC Therapeutics USD 83.33M 445K Jun/2026
Sarepta Therapeutics USD 107.23M 1.61M Sep/2026